N@N

John Roberts Maintained (CC) at Sell with Increased Target to $27 on, Feb 10th, 2023

John Roberts of Credit Suisse, Maintained "The Chemours Company" (CC) at Sell with Increased Target from $24 to $27 on, Feb 10th, 2023.

John has made no other calls on CC in the last 4 months.

There are 7 other peers that have a rating on CC. Out of the 7 peers that are also analyzing CC, 4 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Arun Viswanathan of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $33 on, Tuesday, January 10th, 2023
• PJ Juvekar of "Citigroup" Maintained at Hold with Increased Target to $33 on, Thursday, December 15th, 2022
• Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $33 on, Tuesday, October 25th, 2022
• Duffy Fischer of "Goldman Sachs" Initiated at Hold and Held Target at $30 on, Thursday, October 13th, 2022

These are the ratings of the 3 analyists that currently disagree with John

---

• Joshua Spector of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $43 on, Tuesday, January 24th, 2023
• Matthew DeYoe of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $40 on, Wednesday, January 11th, 2023
• John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $41 on, Thursday, October 27th, 2022

Contributing Sources

---